{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T01:29:28Z","timestamp":1781227768226,"version":"3.54.1"},"reference-count":89,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,29]],"date-time":"2024-09-29T00:00:00Z","timestamp":1727568000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010585","name":"Basque Government Department of Health","doi-asserted-by":"publisher","award":["2020111045"],"award-info":[{"award-number":["2020111045"]}],"id":[{"id":"10.13039\/501100010585","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019179","name":"Fundaci\u00f3n Bancaria Caixa d'Estalvis i Pensions de Barcelona","doi-asserted-by":"publisher","award":["100010434"],"award-info":[{"award-number":["100010434"]}],"id":[{"id":"10.13039\/501100019179","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019179","name":"Fundaci\u00f3n Bancaria Caixa d'Estalvis i Pensions de Barcelona","doi-asserted-by":"publisher","award":["LCF\/BQ\/DI22\/11940012"],"award-info":[{"award-number":["LCF\/BQ\/DI22\/11940012"]}],"id":[{"id":"10.13039\/501100019179","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"EU Framework Programme for Research and Innovation Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["H2020-MSCA-COFUND-2020-101034228-WOLFRAM2"],"award-info":[{"award-number":["H2020-MSCA-COFUND-2020-101034228-WOLFRAM2"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002704","name":"Spanish Association Against Cancer Scientific Foundation","doi-asserted-by":"publisher","award":["PRDVZ234209AMAR"],"award-info":[{"award-number":["PRDVZ234209AMAR"]}],"id":[{"id":"10.13039\/501100002704","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002704","name":"Spanish Association Against Cancer Scientific Foundation","doi-asserted-by":"publisher","award":["PRDVZ21440ASTA"],"award-info":[{"award-number":["PRDVZ21440ASTA"]}],"id":[{"id":"10.13039\/501100002704","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003989","name":"Ikerbasque, Basque Foundation for Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003989","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003086","name":"Eusko Jaurlaritza","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003086","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jinf.2024.106304","type":"journal-article","created":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T02:16:29Z","timestamp":1728094589000},"page":"106304","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["CD151 identifies an NK cell subset that is enriched in COVID-19 patients and correlates with disease severity"],"prefix":"10.1016","volume":"89","author":[{"given":"Ainhoa","family":"Amarilla-Irusta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0869-9034","authenticated-orcid":false,"given":"Olatz","family":"Zenarruzabeitia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4860-3359","authenticated-orcid":false,"given":"Arrate","family":"Sevilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00edctor","family":"Sand\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ainara","family":"Lopez-Pardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabirel","family":"Astarloa-Pando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"P\u00e9rez-Garay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"P\u00e9rez-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9712-1208","authenticated-orcid":false,"given":"Susana","family":"Meijide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natale","family":"Imaz-Ayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunate","family":"Arana-Arri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0322-0167","authenticated-orcid":false,"given":"Laura","family":"Amo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3105-981X","authenticated-orcid":false,"given":"Francisco","family":"Borrego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6508","key":"10.1016\/j.jinf.2024.106304_bib1","doi-asserted-by":"crossref","DOI":"10.1126\/science.abc8511","article-title":"Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications","volume":"369","author":"Mathew","year":"2020","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.jinf.2024.106304_bib2","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/pai.13271","article-title":"The first, holistic immunological model of COVID-19: implications for prevention, diagnosis, and public health measures","volume":"31","author":"Matricardi","year":"2020","journal-title":"Pediatr Allergy Immunol"},{"issue":"10223","key":"10.1016\/j.jinf.2024.106304_bib3","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"issue":"10223","key":"10.1016\/j.jinf.2024.106304_bib4","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jinf.2024.106304_bib5","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1093\/infdis\/jiaa363","article-title":"Serum cytokine and chemokine profile in relation to the severity of coronavirus disease 2019 in China","volume":"222","author":"Chi","year":"2020","journal-title":"J Infect Dis"},{"issue":"10229","key":"10.1016\/j.jinf.2024.106304_bib6","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.jinf.2024.106304_bib7","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.3390\/ijms21093330","article-title":"Cytokine release syndrome in COVID-19 patients, a new scenario for an old concern: the fragile balance between infections and autoimmunity","volume":"21","author":"Diamanti","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"23","key":"10.1016\/j.jinf.2024.106304_bib8","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine storm","volume":"383","author":"Fajgenbaum","year":"2020","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jinf.2024.106304_bib9","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ajpath.2020.08.009","article-title":"Immunopathology of hyperinflammation in COVID-19","volume":"191","author":"Gustine","year":"2021","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jinf.2024.106304_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103390","article-title":"AI-guided discovery of the invariant host response to viral pandemics","volume":"68","author":"Sahoo","year":"2021","journal-title":"EBioMedicine"},{"issue":"5","key":"10.1016\/j.jinf.2024.106304_bib11","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1172\/JCI137244","article-title":"Clinical and immunological features of severe and moderate coronavirus disease 2019","volume":"130","author":"Chen","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jinf.2024.106304_bib12","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.coviro.2015.10.008","article-title":"Roles of natural killer cells in antiviral immunity","volume":"16","author":"Waggoner","year":"2020","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.jinf.2024.106304_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.888248","article-title":"Natural killer cells in SARS-CoV-2 infection: pathophysiology and therapeutic implications","volume":"13","author":"Di Vito","year":"2022","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.jinf.2024.106304_bib14","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1182\/blood-2007-09-077438","article-title":"Human natural killer cells","volume":"112","author":"Caligiuri","year":"2008","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jinf.2024.106304_bib15","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.immuni.2017.10.008","article-title":"The broad spectrum of human natural killer cell diversity","volume":"47","author":"Freud","year":"2017","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.jinf.2024.106304_bib16","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/nri.2016.34","article-title":"Emerging insights into natural killer cells in human peripheral tissues","volume":"16","author":"Bj\u00f6rkstr\u00f6m","year":"2016","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"10.1016\/j.jinf.2024.106304_bib17","doi-asserted-by":"crossref","first-page":"4694","DOI":"10.1172\/JCI138554","article-title":"Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent","volume":"130","author":"Mazzoni","year":"2020","journal-title":"J Clin Invest"},{"issue":"20","key":"10.1016\/j.jinf.2024.106304_bib18","doi-asserted-by":"crossref","first-page":"5035","DOI":"10.1182\/bloodadvances.2020002650","article-title":"Impaired natural killer cell counts and cytolytic activity in patients with severe COVID-19","volume":"4","author":"Osman","year":"2020","journal-title":"Blood Adv"},{"issue":"5","key":"10.1016\/j.jinf.2024.106304_bib19","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41423-020-0402-2","article-title":"Functional exhaustion of antiviral lymphocytes in COVID-19 patients","volume":"17","author":"Zheng","year":"2020","journal-title":"Cell Mol Immunol"},{"issue":"50","key":"10.1016\/j.jinf.2024.106304_bib20","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abd6832","article-title":"Natural killer cell immunotypes related to COVID-19 disease severity","volume":"5","author":"Maucourant","year":"2020","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jinf.2024.106304_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.834862","article-title":"Comparison of lung-homing receptor expression and activation profiles on NK Cell and T cell subsets in COVID-19 and influenza","volume":"13","author":"Brownlie","year":"2022","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.jinf.2024.106304_bib22","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/s41591-020-0901-9","article-title":"Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19","volume":"26","author":"Liao","year":"2020","journal-title":"Nat Med"},{"issue":"11","key":"10.1016\/j.jinf.2024.106304_bib23","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1016\/j.immuni.2021.09.002","article-title":"Early IFN-\u03b1 signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19","volume":"54","author":"Kr\u00e4mer","year":"2021","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.jinf.2024.106304_bib24","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/s41422-020-00455-9","article-title":"Discriminating mild from critical COVID-19 by innate and adaptive immune single-cell profiling of bronchoalveolar lavages","volume":"31","author":"Wauters","year":"2021","journal-title":"Cell Res"},{"key":"10.1016\/j.jinf.2024.106304_bib25","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.3389\/fimmu.2018.01671","article-title":"Human CD49a+ lung natural killer cell cytotoxicity in response to influenza A virus","volume":"9","author":"Cooper","year":"2018","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.jinf.2024.106304_bib26","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/biof.107","article-title":"Cytokine regulation of natural killer cell effector functions","volume":"36","author":"Zwirner","year":"2010","journal-title":"BioFactors"},{"key":"10.1016\/j.jinf.2024.106304_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.861251","article-title":"Severe COVID-19 patients display hyper-activated NK cells and NK cell-platelet aggregates","volume":"13","author":"Malengier-Devlies","year":"2022","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.jinf.2024.106304_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009448","article-title":"Extensive activation, tissue trafficking, turnover and functional impairment of NK cells in COVID-19 patients at disease onset associates with subsequent disease severity","volume":"17","author":"Bozzano","year":"2021","journal-title":"PLoS Pathog"},{"issue":"1","key":"10.1016\/j.jinf.2024.106304_bib29","doi-asserted-by":"crossref","first-page":"3841","DOI":"10.1038\/s41467-019-11632-9","article-title":"Unique transcriptional and protein-expression signature in human lung tissue-resident NK cells","volume":"10","author":"Marquardt","year":"2019","journal-title":"Nat Commun"},{"issue":"12","key":"10.1016\/j.jinf.2024.106304_bib30","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.4049\/jimmunol.1900866","article-title":"TGF-\u03b2 and IL-15 Synergize through MAPK pathways to drive the conversion of human NK Cells to an innate lymphoid cell 1\u2013like phenotype","volume":"204","author":"Hawke","year":"2020","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.jinf.2024.106304_bib31","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1084\/jem.20030305","article-title":"Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential","volume":"198","author":"Koopman","year":"2003","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.jinf.2024.106304_bib32","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1158\/2159-8290.CD-20-0796","article-title":"Decidual-like NK cell polarization: from cancer killing to cancer nurturing","volume":"11","author":"Albini","year":"2021","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jinf.2024.106304_bib33","article-title":"Human-induced CD49a+ NK cells promote fetal growth","volume":"13","author":"Du","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jinf.2024.106304_bib34","article-title":"Uterine natural killer cells: a rising star in human pregnancy regulation","volume":"13","author":"Xie","year":"2022","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.jinf.2024.106304_bib35","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.it.2003.09.011","article-title":"Tetraspanins: molecular organisers of the leukocyte surface","volume":"24","author":"Tarrant","year":"2003","journal-title":"Trends Immunol"},{"issue":"1","key":"10.1016\/j.jinf.2024.106304_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-72719-8","article-title":"The tetraspanin CD151 marks a unique population of activated human T cells","volume":"10","author":"Perez","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jinf.2024.106304_bib37","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1084\/jem.180.4.1395","article-title":"Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor","volume":"180","author":"Carson","year":"1994","journal-title":"J Exp Med"},{"issue":"3","key":"10.1016\/j.jinf.2024.106304_bib38","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1158\/1078-0432.CCR-16-2478","article-title":"Natural killer cells to the attack: combination therapy against neuroblastoma","volume":"23","author":"Zenarruzabeitia","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"7888","key":"10.1016\/j.jinf.2024.106304_bib39","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41586-021-04142-6","article-title":"Untimely TGF\u03b2 responses in COVID-19 limit antiviral functions of NK cells","volume":"600","author":"Witkowski","year":"2021","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.jinf.2024.106304_bib40","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1002\/JLB.3COVBCR0621-300R","article-title":"Opposing roles for sMAdCAM and IL-15 in COVID-19 associated cellular immune pathology","volume":"111","author":"Singh","year":"2022","journal-title":"J Leukoc Biol"},{"issue":"3","key":"10.1016\/j.jinf.2024.106304_bib41","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.3390\/ijms24031996","article-title":"Coordinated loss and acquisition of NK cell surface markers accompanied by generalized cytokine dysregulation in COVID-19","volume":"24","author":"Ustiuzhanina","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"15","key":"10.1016\/j.jinf.2024.106304_bib42","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1158\/1078-0432.CCR-10-0705","article-title":"GDF-15 contributes to proliferation and immune escape of malignant gliomas","volume":"16","author":"Roth","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jinf.2024.106304_bib43","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.ebiom.2019.04.018","article-title":"Circulating growth\/differentiation factor 15 is associated with human CD56bright natural killer cell dysfunction and nosocomial infection in severe systemic inflammation","volume":"43","author":"Kleinertz","year":"2019","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.jinf.2024.106304_bib44","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3390\/life12010013","article-title":"Major surgical trauma impairs the function of natural killer cells but does not affect monocyte cytokine synthesis","volume":"12","author":"M\u00fcller-Heck","year":"2022","journal-title":"Life"},{"key":"10.1016\/j.jinf.2024.106304_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/09513590.2020.1816715","article-title":"The uteroplacental contact zone cytokine influence on NK cell cytotoxicity to trophoblasts","volume":"36","author":"Bazhenov","year":"2020","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.jinf.2024.106304_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.798338","article-title":"Cytokine elevation in severe COVID-19 from longitudinal proteomics analysis: comparison with sepsis","volume":"12","author":"Ebihara","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jinf.2024.106304_bib47","doi-asserted-by":"crossref","first-page":"951","DOI":"10.3389\/fimmu.2020.00951","article-title":"Growth\/differentiation factor-15 (GDF-15): from biomarker to novel targetable immune checkpoint","volume":"11","author":"Wischhusen","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jinf.2024.106304_bib48","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.64827","article-title":"Longitudinal proteomic profiling of dialysis patients with COVID-19 reveals markers of severity and predictors of death","volume":"10","author":"Gisby","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.jinf.2024.106304_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.820350","article-title":"Coping with stress: the mitokine GDF-15 as a biomarker of COVID-19 severity","volume":"13","author":"Ahmed","year":"2022","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.jinf.2024.106304_bib50","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1056\/NEJMoa055352","article-title":"Soluble endoglin and other circulating antiangiogenic factors in preeclampsia","volume":"335","author":"Levine","year":"2006","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.jinf.2024.106304_bib51","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1111\/jth.15339","article-title":"Placental growth factor level in plasma predicts COVID-19 severity and in-hospital mortality","volume":"19","author":"Smadja","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jinf.2024.106304_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.964179","article-title":"Inflammatory mediators profile in patients hospitalized with COVID-19: a comparative study","volume":"13","author":"Tufa","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jinf.2024.106304_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.655934","article-title":"T cell activation, highly armed cytotoxic cells and a shift in monocytes CD300 receptors expression is characteristic of patients with severe COVID-19","volume":"12","author":"Zenarruzabeitia","year":"2021","journal-title":"Front Immunol"},{"issue":"15","key":"10.1016\/j.jinf.2024.106304_bib54","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/cid\/ciaa248","article-title":"Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China","volume":"71","author":"Qin","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.jinf.2024.106304_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101298","article-title":"A NKp80-based identification strategy reveals that CD56neg NK cells are not completely dysfunctional in health and disease","volume":"23","author":"Orrantia","year":"2020","journal-title":"iScience"},{"issue":"6","key":"10.1016\/j.jinf.2024.106304_bib56","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/nri3839","article-title":"Perforin and granzymes: function, dysfunction and human pathology","volume":"15","author":"Voskoboinik","year":"2015","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"10.1016\/j.jinf.2024.106304_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124677","article-title":"A human anti-M2 antibody mediates antibody-dependent cell-mediated cytotoxicity (ADCC) and cytokine secretion by resting and cytokine-preactivated natural killer (NK) cells","volume":"10","author":"Simhadri","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.jinf.2024.106304_bib58","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1365-2567.2008.03027.x","article-title":"CD56bright natural killer (NK) cells: an important NK cell subset","volume":"126","author":"Poli","year":"2009","journal-title":"Immunology"},{"issue":"5","key":"10.1016\/j.jinf.2024.106304_bib59","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jinf.2021.03.008","article-title":"IL-6 inhibition in the treatment of COVID-19: a meta-analysis and meta-regression","volume":"82","author":"Tharmarajah","year":"2021","journal-title":"J Infect"},{"key":"10.1016\/j.jinf.2024.106304_bib60","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0065-2776(04)86006-1","article-title":"Interleukin-2, interleukin-15, and their roles in human natural killer cells","volume":"86","author":"Becknell","year":"2005","journal-title":"Adv Immunol"},{"issue":"3","key":"10.1016\/j.jinf.2024.106304_bib61","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.cyto.2012.05.020","article-title":"Functions of IL-15 in anti-viral immunity: multiplicity and variety","volume":"59","author":"Verbist","year":"2012","journal-title":"Cytokine"},{"issue":"8","key":"10.1016\/j.jinf.2024.106304_bib62","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/ni.2936","article-title":"The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells","volume":"15","author":"Mar\u00e7ais","year":"2014","journal-title":"Nat Immunol"},{"issue":"1","key":"10.1016\/j.jinf.2024.106304_bib63","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.144455","article-title":"An immune-based biomarker signature is associated with mortality in COVID-19 patients","volume":"6","author":"Abers","year":"2021","journal-title":"JCI Insight"},{"issue":"11","key":"10.1016\/j.jinf.2024.106304_bib64","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/s41419-020-03151-z","article-title":"Age-severity matched cytokine profiling reveals specific signatures in Covid-19 patients","volume":"11","author":"Angioni","year":"2020","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.jinf.2024.106304_bib65","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41392-022-00892-5","article-title":"NK cell dysfunction in severe COVID-19: TGF-\u03b2-induced downregulation of integrin beta-2 restricts NK cell cytotoxicity","volume":"7","author":"Barros-Martins","year":"2022","journal-title":"Signal Transduct Target Ther"},{"issue":"9","key":"10.1016\/j.jinf.2024.106304_bib66","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.3390\/diagnostics12092051","article-title":"The potential role of growth differentiation factor 15 in COVID-19: a corollary subjective effect or not?","volume":"12","author":"Babalghith","year":"2022","journal-title":"Diagnostics"},{"issue":"12","key":"10.1016\/j.jinf.2024.106304_bib67","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.3390\/ijms20122970","article-title":"Multifaceted role of the placental growth factor (PLGF) in the antitumor immune response and cancer progression","volume":"20","author":"Albonici","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.jinf.2024.106304_bib68","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/87904","article-title":"Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions","volume":"7","author":"Carmeliet","year":"2001","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.jinf.2024.106304_bib69","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/s41423-020-00557-9","article-title":"Unique immunological profile in patients with COVID-19","volume":"18","author":"Varchetta","year":"2021","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"10.1016\/j.jinf.2024.106304_bib70","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1053\/j.gastro.2015.03.004","article-title":"Successful interferon-free therapy of chronic hepatitis C virus infection normalizes natural killer cell function","volume":"149","author":"Serti","year":"2015","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.jinf.2024.106304_bib71","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1002\/eji.201041180","article-title":"A distinct subset of human NK cells expressing HLA-DR expand in response to IL-2 and can aid immune responses to BCG","volume":"41","author":"Evans","year":"2011","journal-title":"Eur J Immunol"},{"issue":"2","key":"10.1016\/j.jinf.2024.106304_bib72","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/JLB.3RU0420-668RR","article-title":"HLA-DR-expressing NK cells: effective killers suspected for antigen presentation","volume":"109","author":"Erokhina","year":"2021","journal-title":"J Leukoc Biol"},{"issue":"2","key":"10.1016\/j.jinf.2024.106304_bib73","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/imcb.1032","article-title":"HLA-DR+ NK cells are mostly characterized by less mature phenotype and high functional activity","volume":"96","author":"Erokhina","year":"2018","journal-title":"Immunol Cell Biol"},{"issue":"2","key":"10.1016\/j.jinf.2024.106304_bib74","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1365-2249.2006.02996.x","article-title":"NK cells, displaying early activation, cytotoxicity and adhesion molecules, are associated with mild dengue disease","volume":"143","author":"Azeredo","year":"2006","journal-title":"Clin Exp Immunol"},{"issue":"9","key":"10.1016\/j.jinf.2024.106304_bib75","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1097\/QAD.0000000000000286","article-title":"Impaired natural killer cell responses are associated with loss of the highly activated NKG2A+CD57+CD56dim subset in HIV-1 subtype D infection in Uganda","volume":"28","author":"Naluyima","year":"2014","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.jinf.2024.106304_bib76","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0167640","article-title":"Increased natural killer cell activation in HIV- infected immunologic non-responders correlates with CD4+ T cell recovery after antiretroviral therapy and viral suppression","volume":"12","author":"Luo","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jinf.2024.106304_bib77","doi-asserted-by":"crossref","first-page":"687","DOI":"10.3389\/fimmu.2019.00687","article-title":"Human cytomegalovirus antigen presentation by HLA-DR+ NKG2C+ adaptive NK cells specifically activates polyfunctional effector memory CD4+ T lymphocytes","volume":"10","author":"Costa-Garc\u00eda","year":"2019","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.jinf.2024.106304_bib78","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2023.2208679","article-title":"The unreversible reduced but persistent activated NK and CD8+ T cells in severe\/critical COVID-19 during omicron pandemic in China","volume":"12","author":"Qin","year":"2023","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.jinf.2024.106304_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108516","article-title":"COVID-19 pneumonia: CD8+ T and NK cells are decreased in number but compensatory increased in cytotoxic potential","volume":"218","author":"Jiang","year":"2020","journal-title":"Clin Immunol"},{"issue":"5","key":"10.1016\/j.jinf.2024.106304_bib80","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/jleuko\/qiad031","article-title":"NK cells in COVID-19-from disease to vaccination","volume":"114","author":"Hammer","year":"2023","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jinf.2024.106304_bib81","article-title":"CD160 promotes NK cell functions by upregulating glucose metabolism and negatively correlates with HIV disease progression","volume":"13","author":"Sun","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jinf.2024.106304_bib82","first-page":"23","article-title":"Signal transduction in natural killer cells","volume":"298","author":"MacFarlane","year":"2006","journal-title":"Curr Top Microbiol Immunol"},{"issue":"11","key":"10.1016\/j.jinf.2024.106304_bib83","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1242\/jcs.124099","article-title":"An immunologist\u2019s guide to CD31 function in T-cells","volume":"126","author":"Marelli-Berg","year":"2013","journal-title":"J Cell Sci"},{"issue":"1","key":"10.1016\/j.jinf.2024.106304_bib84","doi-asserted-by":"crossref","first-page":"7109","DOI":"10.1038\/s41467-023-42990-0","article-title":"IL-21R-STAT3 signalling initiates a differentiation program in uterine tissue-resident NK cells to support pregnancy","volume":"14","author":"Han","year":"2023","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.jinf.2024.106304_bib85","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/j.0022-202X.2005.23882.x","article-title":"Role of tetraspanins CD9 and CD151 in primary melanocyte motility","volume":"125","author":"Garc\u00eda-L\u00f3pez","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jinf.2024.106304_bib86","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.3389\/fimmu.2019.01397","article-title":"Features of human decidual NK cells in healthy pregnancy and during viral infection","volume":"10","author":"Jabrane-Ferrat","year":"2019","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.jinf.2024.106304_bib87","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.4049\/jimmunol.1202582","article-title":"Conversion of peripheral blood NK cells to a decidual NK-like phenotype by a cocktail of defined factors","volume":"190","author":"Cerdeira","year":"2013","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.jinf.2024.106304_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.105235","article-title":"In vivo expansion of a CD9+ decidual-like NK cell subset following autologous hematopoietic stem cell transplantation","volume":"25","author":"Orrantia","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.jinf.2024.106304_bib89","article-title":"Activated NK cells with a predominance of inhibitory receptors and a decidual-like phenotype expand after autologous HSCT in children with tumors","author":"Astarloa-Pando","year":"2024","journal-title":"bioRxiv"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016344532400238X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016344532400238X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T11:00:09Z","timestamp":1778670009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016344532400238X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":89,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S016344532400238X"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2024.106304","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CD151 identifies an NK cell subset that is enriched in COVID-19 patients and correlates with disease severity","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2024.106304","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd on behalf of The British Infection Association.","name":"copyright","label":"Copyright"}],"article-number":"106304"}}